By Jimmy Hoover ( May 5, 2016, 3:53 PM EDT) -- Generic drugmaker Hospira urged the full Federal Circuit bench Thursday not to exempt medicine-manufacturing contracts from the types of product sales that bar patent applications, arguing such a "sweeping change" in the law would discourage early patent filings and damage the system as a whole....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.